What drove Novartis (NOVN.SW) to be most active on 19 Jan 2026?

NOVN.SW stock was most active due to ETF rebalancing, high liquidity and positioning ahead of earnings on 04 Feb 2026. Volume reached 2,530,491.00 shares while price traded near **CHF115.56**, attracting institutional flows

How is Novartis valued versus its healthcare peers?

Novartis trades at PE **19.75** and price-to-sales **4.90**, below the sector average PE **33.79**. The lower PE suggests relative valuation support against Swiss healthcare peers

What is Meyka AI's view and grade for NOVN.SW stock?

Meyka AI rates NOVN.SW **75.11/100 (Grade B+, Suggestion: BUY)**. The grade factors in benchmarks, sector performance, financial growth, key metrics and consensus. Grades are informational, not investment advice

What forecast should investors watch for NOVN.SW stock?

Meyka AI's forecast model projects **CHF100.53** at 1 year and **CHF112.11** at 3 years versus the current **CHF115.56**. These are model projections and not guarantees

CH Stocks

Most active: Novartis NOVN.SW (SIX) closed 19 Jan 2026: CHF115.56 outlook

ByDanny Kontos January 20, 2026January 20, 2026

NOVN.SW stock closed the Swiss SIX session at CHF115.56 on 19 Jan 2026 after trading 2,530,491.00 shares, keeping Novartis AG among the day’s most active names. The price finished within a CHF115.18–116.16 range and near its 52-week high of CHF116.78. Market participants focused on valuation and upcoming results with consensus earnings set for early February. We review intraday flows, valuation, technical signals and a model forecast to explain why Novartis (NOVN.SW) led activity on the SIX while markets were closed